CytoMed Therapeutics
GDTC
#9834
Rank
S$37 M
Marketcap
$3.21
Share price
-4.03%
Change (1 day)
16.47%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for CytoMed Therapeutics CIK: 0001873093
The 20-F is a 10-K equivalent for non-US companies, as a foreight company CytoMed Therapeutics only files 20-F reports

Thumbnail CytoMed Therapeutics 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail CytoMed Therapeutics 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)